Literature DB >> 2458683

Depression associated with nifedipine-induced calcium channel blockade.

F J Hullett1, S G Potkin, A B Levy, R Ciasca.   

Abstract

Four cases are reported in which substantial depression was associated with the use of the calcium channel blocker nifedipine. In one instance, a patient became unresponsive to treatment with nortriptyline when nifedipine was introduced. In each case, the depression resolved following discontinuation of nifedipine. Possible mechanisms by which nifedipine may influence affective states are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458683     DOI: 10.1176/ajp.145.10.1277

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

Authors:  H T Sørensen; L Mellemkjaer; J H Olsen
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 2.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.

Authors:  Cheng Jiang; Wei-Jye Lin; Benoit Labonté; Carol A Tamminga; Gustavo Turecki; Eric J Nestler; Scott J Russo; Stephen R Salton
Journal:  Neuropsychopharmacology       Date:  2018-11-20       Impact factor: 7.853

4.  Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is established.

Authors:  U Bergman; G Isacsson
Journal:  BMJ       Date:  1998-10-17

5.  Depression associated with diltiazem.

Authors:  C Biriell; J McEwen; E Sanz
Journal:  BMJ       Date:  1989-09-23

6.  Does Ca2+ channel blockade modulate the antidepressant-induced changes in mechanisms of adrenergic transduction?

Authors:  I Nalepa; M Kowalska; G Kreiner; J Vetulani
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 7.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 8.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

9.  Association between antihypertensive medication use and non-cardiovascular outcomes in older men.

Authors:  Joseph V Agostini; Mary E Tinetti; Ling Han; Peter Peduzzi; Joanne M Foody; John Concato
Journal:  J Gen Intern Med       Date:  2007-09-25       Impact factor: 5.128

Review 10.  Quality of life in the treatment of hypertension. The effect of calcium antagonists.

Authors:  A Fletcher; C Bulpitt
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.